Laloui, K., Wary, C., Carlier, R. Y., Hogrel, J. Y., Caillaud, C., Laforet, P. :
Making diagnosis of Pompe disease at a presymptomatic stage: To treat or not to treat ?
Neurology, 2011 ; 77 (6) : 594-5
Publications (1181)
Schlossarek, S., Carrier, L. :
The ubiquitin-proteasome system in cardiomyopathies Curr Opin Cardiol, 2011 ; 26 (3) : 190-195
The ubiquitin-proteasome system in cardiomyopathies Curr Opin Cardiol, 2011 ; 26 (3) : 190-195
Bonnefont, J. P., Bastin, J., Laforet, P., Aubey, F., Mogenet, A., Romano, S., Ricquier, D., Gobin-Limballe, S., Vassault, A., Behin, A., Eymard, B., Bresson, J. L., Djouadi, F. :
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency Clin Pharmacol Ther, 2010 ; 88 (1) : 101-8
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency Clin Pharmacol Ther, 2010 ; 88 (1) : 101-8
Hayashi, Shinichiro, Drayton, Bernadette, Aurade, Frédéric, Rocancourt, Didier, Buckingham, Margaret, Relaix, Frédéric :
Conserved functions of Pax3/7 during evolution Developmental Biology, 2010 ; 344 (1) : 528-529
Conserved functions of Pax3/7 during evolution Developmental Biology, 2010 ; 344 (1) : 528-529
Pinto Mariz, F, Carvalho, L. R., De Mello, W., De Queiroz Campos Araujo, A, Ribeiro, M. G., Do Carmo Soares Alves Cunha, M, Voit , T, Butler Browne, G., Dayse Silva Barbosa, S :
Differential integrin expression by T lymphocytes: potential role in DMD muscle damage J Neuroimmunol, 2010 ; 223 (1-2) : 128-130
Differential integrin expression by T lymphocytes: potential role in DMD muscle damage J Neuroimmunol, 2010 ; 223 (1-2) : 128-130
Laforêt, P :
Cerebral vessel involvement in Pompe disease. The Steps Forward in Pompe Disease -3rd European Symposium, Munich, Germany, November 20 and 21 2009 Clin Ther, 2010 ; 32 (Supplement 2) : S51
Cerebral vessel involvement in Pompe disease. The Steps Forward in Pompe Disease -3rd European Symposium, Munich, Germany, November 20 and 21 2009 Clin Ther, 2010 ; 32 (Supplement 2) : S51
Claeys, K. G., Pellissier, J. F., Garcia-Bragado, F., Weis, J., Urtizberea, A., Poza, J. J., Cobo, A. M., Stoltenburg, G., Figarella-Branger, D., Willems, P. J., Depuydt, C. E., Kleiner, W., Pouget, J., Piraud, M., Brochier, G., Romero, N. B., Fardeau, M., Goebel, H. H., Bonnemann, C. G., Voit, T., Eymard, B., Laforet, P. :
Myopathy with hexagonally cross-linked crystalloid inclusions: Delineation of a clinico-pathological entity Neuromuscul Disord, 2010 ; 20 (11) : 701-708
Myopathy with hexagonally cross-linked crystalloid inclusions: Delineation of a clinico-pathological entity Neuromuscul Disord, 2010 ; 20 (11) : 701-708
Le Panse, R., Bismuth, J., Cizeron-Clairac, G., Weiss, J. M., Cufi, P., Dartevelle, P., De Rosbo, N. K., Berrih-Aknin, S. :
Thymic remodeling associated with hyperplasia in myasthenia gravis Autoimmunity, 2010 ; 43 (5-6) : 401-12
Thymic remodeling associated with hyperplasia in myasthenia gravis Autoimmunity, 2010 ; 43 (5-6) : 401-12
Trollet, C., Anvar, S. Y., Venema, A., Hargreaves, I. P., Foster, K., Vignaud, A., Ferry, A., Negroni, E., Hourde, C., Baraibar, M. A., t Hoen, P. A., Davies, J. E., Rubinsztein, D. C., Heales, S. J., Mouly, V., Raz, V., Butler-Browne, G., van der Maarel, S. M., Dickson, G. :
Molecular and phenotypic characterisation of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres Hum Mol Genet, 2010 ; 19 (11) : 2191-21207
Molecular and phenotypic characterisation of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres Hum Mol Genet, 2010 ; 19 (11) : 2191-21207
Arzel-Hezode, M., Sternberg, D., Tabti, N., Vicart, S., Goizet, C., Eymard, B., Fontaine, B., Fournier, E. :
Homozygosity for dominant mutations increases severity of muscle channelopathies Muscle Nerve, 2010 ; 41 (4) : 470-7
Homozygosity for dominant mutations increases severity of muscle channelopathies Muscle Nerve, 2010 ; 41 (4) : 470-7
